Amgen Inc (AMGN)
270.05
+0.67
(+0.25%)
USD |
NASDAQ |
Apr 26, 16:00
270.05
0.00 (0.00%)
After-Hours: 20:00
Amgen Price to Book Value: 23.22 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 23.17 |
| April 24, 2024 | 23.48 |
| April 23, 2024 | 23.52 |
| April 22, 2024 | 23.38 |
| April 19, 2024 | 23.13 |
| April 18, 2024 | 22.60 |
| April 17, 2024 | 22.71 |
| April 16, 2024 | 22.84 |
| April 15, 2024 | 22.83 |
| April 12, 2024 | 22.98 |
| April 11, 2024 | 23.22 |
| April 10, 2024 | 22.91 |
| April 09, 2024 | 23.25 |
| April 08, 2024 | 23.15 |
| April 05, 2024 | 23.21 |
| April 04, 2024 | 23.05 |
| April 03, 2024 | 23.60 |
| April 02, 2024 | 23.75 |
| April 01, 2024 | 24.34 |
| March 28, 2024 | 24.45 |
| March 27, 2024 | 24.62 |
| March 26, 2024 | 24.23 |
| March 25, 2024 | 24.15 |
| March 22, 2024 | 23.75 |
| March 21, 2024 | 23.82 |
| Date | Value |
|---|---|
| March 20, 2024 | 23.48 |
| March 19, 2024 | 23.37 |
| March 18, 2024 | 23.30 |
| March 15, 2024 | 23.12 |
| March 14, 2024 | 23.35 |
| March 13, 2024 | 23.73 |
| March 12, 2024 | 23.78 |
| March 11, 2024 | 23.68 |
| March 08, 2024 | 23.54 |
| March 07, 2024 | 23.46 |
| March 06, 2024 | 23.79 |
| March 05, 2024 | 23.79 |
| March 04, 2024 | 24.03 |
| March 01, 2024 | 24.11 |
| February 29, 2024 | 23.55 |
| February 28, 2024 | 23.86 |
| February 27, 2024 | 23.95 |
| February 26, 2024 | 24.63 |
| February 23, 2024 | 24.87 |
| February 22, 2024 | 24.52 |
| February 21, 2024 | 24.38 |
| February 20, 2024 | 24.38 |
| February 16, 2024 | 24.40 |
| February 15, 2024 | 24.86 |
| February 14, 2024 | 24.94 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
9.387
Minimum
May 31 2019
149.73
Maximum
May 31 2022
26.27
Average
15.62
Median
Aug 18 2021
Price to Book Value Benchmarks
| Gilead Sciences Inc | 3.569 |
| Johnson & Johnson | 5.106 |
| Eli Lilly and Co | 64.73 |
| Merck & Co Inc | 8.841 |
| Vertex Pharmaceuticals Inc | 5.839 |
Price to Book Value Related Metrics
| PE Ratio | 21.62 |
| PS Ratio | 5.151 |
| PEG Ratio | 6.890 |
| Price to Free Cash Flow | 19.73 |
| Price | 270.05 |
| Earnings Yield | 4.63% |
| Market Cap | 144.72B |
| PEGY Ratio | 3.407 |
| Operating PE Ratio | 18.39 |
| Normalized PE Ratio | 21.62 |